Zimmer Biomet Group Holdings Inc. 11.09.18
Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, announced that Ivan Tornos has joined the company as group president of Orthopedics.
“Ivan is a great addition to our leadership team, bringing deep medical technology expertise and a strong history of successfully managing complex businesses across several continents,” said Bryan Hanson, president and CEO of Zimmer Biomet. “Ivan’s exceptional track record of executing on commercial strategies and driving growth and profitability will be critical to Zimmer Biomet as we continue our focus on achieving sustained performance in the business.”
Tornos comes to Zimmer Biomet having served for more than two decades in various global roles for Fortune 50 to 500 companies. In this newly created position, Tornos will be responsible for increased innovation, implementation and execution of the Orthopedics group, which will include our large joint, sports, extremities and trauma (S.E.T.) businesses as well as the Americas region.
Prior to joining Zimmer Biomet, Tornos served as worldwide president of the Global Urology/Medical and Critical Care Division of Becton, Dickinson and Company. Prior to that, he was with C.R. Bard, most recently serving as president of Europe, Middle East and Africa Regions. Before joining C.R. Bard, Tornos served as vice president and general manager of the Americas Pharmaceutical and Medical/Imaging segments of Covidien International. Before that, Tornos served as international vice president of Business Development and Strategy at Baxter International Inc. and prior to that, he spent 11 years with Johnson & Johnson in positions of increasing responsibility.
Tornos is an alumnus of the Harvard Business School, having graduated from the Advanced Management Program (AMP 187) and also completed leadership and management programs at the Cox School of Business of Southern Methodist University. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD marketing/finance), holds an MBA from the University of Miami School of Business and a BBA in finance and international marketing and management from the University of Georgia Terry College of Business.
Founded in 1927 and headquartered in Warsaw, Ind., Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. The company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet has operations in more than 25 countries around the world and sells products in more than 100 countries.
“Ivan is a great addition to our leadership team, bringing deep medical technology expertise and a strong history of successfully managing complex businesses across several continents,” said Bryan Hanson, president and CEO of Zimmer Biomet. “Ivan’s exceptional track record of executing on commercial strategies and driving growth and profitability will be critical to Zimmer Biomet as we continue our focus on achieving sustained performance in the business.”
Tornos comes to Zimmer Biomet having served for more than two decades in various global roles for Fortune 50 to 500 companies. In this newly created position, Tornos will be responsible for increased innovation, implementation and execution of the Orthopedics group, which will include our large joint, sports, extremities and trauma (S.E.T.) businesses as well as the Americas region.
Prior to joining Zimmer Biomet, Tornos served as worldwide president of the Global Urology/Medical and Critical Care Division of Becton, Dickinson and Company. Prior to that, he was with C.R. Bard, most recently serving as president of Europe, Middle East and Africa Regions. Before joining C.R. Bard, Tornos served as vice president and general manager of the Americas Pharmaceutical and Medical/Imaging segments of Covidien International. Before that, Tornos served as international vice president of Business Development and Strategy at Baxter International Inc. and prior to that, he spent 11 years with Johnson & Johnson in positions of increasing responsibility.
Tornos is an alumnus of the Harvard Business School, having graduated from the Advanced Management Program (AMP 187) and also completed leadership and management programs at the Cox School of Business of Southern Methodist University. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD marketing/finance), holds an MBA from the University of Miami School of Business and a BBA in finance and international marketing and management from the University of Georgia Terry College of Business.
Founded in 1927 and headquartered in Warsaw, Ind., Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. The company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet has operations in more than 25 countries around the world and sells products in more than 100 countries.